Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.94
-0.5800-1.90%
Post-market: 29.81-0.1216-0.41%19:30 EDT
Volume:5K
Turnover:145.87K
Market Cap:31.43M
PE:- -
High:30.40
Open:30.40
Low:29.81
Close:30.52
52wk High:33.59
52wk Low:23.00
Shares:1.05M
Float Shares:1.05M
Volume Ratio:0.18
T/O Rate:0.46%
Dividend:0.07
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

DexCom (DXCM) Stock May Be Below Fair Value Following Raised Guidance

Simply Wall St.
·
Aug 01

Stryker Corp Stock (SYK) Moved Down by 6.58% on Jul 31: What Investors Need To Know

TradingKey
·
Aug 01

Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR), Mettler-Toledo (MTD) and Dexcom (DXCM)

TIPRANKS
·
Aug 01

DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says

MT Newswires Live
·
Jul 31

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-07-31

Reuters
·
Jul 31

Early notable gainers among liquid option names on July 31st

TIPRANKS
·
Jul 31

Dexcom Shares Hit One-Year High After Annual Revenue Forecast Raise, Last up 11%

THOMSON REUTERS
·
Jul 31

Dexcom Inc : Citigroup Raises Target Price to $88 from $84

THOMSON REUTERS
·
Jul 31

Tempus AI Price Target Maintained with a $75.00/Share by Needham

Dow Jones
·
Jul 31

Tempus AI Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Dexcom Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Dexcom Inc : Jefferies Raises Target Price to $115 from $112

THOMSON REUTERS
·
Jul 31

Dexcom Inc : JP Morgan Raises Target Price to $82 from $65

THOMSON REUTERS
·
Jul 31

Tempus AI CEO and Chairman Eric Lefkofsky Disposes of USD 10.75 Million in Common Shares

Reuters
·
Jul 31

Dexcom Raises Annual Revenue Forecast on Strong Demand for Glucose Monitors

Reuters
·
Jul 31

Gartner Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jul 31

Tempus AI Inc Shares Fall 2% After the Bell Following Results, Outlook

THOMSON REUTERS
·
Jul 31

GUIDANCE: (TEM) Tempus AI Expects Full Year 2026 Revenue Range $1.595B - $1.605B, vs. FactSet Est of $1.59B

MT Newswires Live
·
Jul 31

Dexcom Reports Higher Profit, Raises FY Sales Outlook

Dow Jones
·
Jul 31

Tempus AI Q2 FY26 Swings to GAAP Profit of $5.64 Million; Revenue Rises 22% to $382.5 Million

Reuters
·
Jul 31